+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine-Based Collagen for Biomedical Applications Market by Product Type (Gelatin, Hydrolyzed Collagen, Native Collagen), Type (Type I, Type III), Form, Source, Processing Technology, Application, End User - Global Forecast 2025-2030- Product Image
Bovine-Based Collagen for Biomedical Applications Market by Product Type (Gelatin, Hydrolyzed Collagen, Native Collagen), Type (Type I, Type III), Form, Source, Processing Technology, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Bovine-Based Collagen for Biomedical Applications Market by Product Type (Gelatin, Hydrolyzed Collagen, Native Collagen), Type (Type I, Type III), Form, Source, Processing Technology, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011094
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bovine-Based Collagen for Biomedical Applications Market grew from USD 1.24 billion in 2024 to USD 1.33 billion in 2025. It is expected to continue growing at a CAGR of 7.71%, reaching USD 1.94 billion by 2030.

Bovine-based collagen has emerged as a pivotal material in the biomedical arena, driving innovations that reshape treatment paradigms and patient care strategies. This comprehensive report explores the origins of collagen derived from bovine sources, highlighting its biochemical properties, biocompatibility, and abundance which have positioned it as a material of choice for applications ranging from tissue engineering to drug delivery systems. The increasing demand for advanced regenerative therapies and surgical reconstructions has accelerated research and investment in bovine-based collagen. Over recent years, stakeholders have witnessed enhanced processing methodologies and quality control measures, ensuring that the material meets rigorous regulatory and clinical standards. Furthermore, advances in extraction and purification techniques have not only augmented product efficiency but also broadened its application spectrum within the biomedical field. In this dynamic environment, a deep understanding of market trends, technology evolutions, and quality differentiators is indispensable for decision-makers aiming to harness the full potential of bovine collagen. The narrative that follows sets the stage for an in-depth analysis, offering insights that are both comprehensive and actionable for industry experts and stakeholders alike.

Transformative Shifts Redefining the Biomedical Landscape

The biomedical landscape has undergone transformative shifts catalyzed by technological advancements and evolving therapeutic demands. Recent innovations in processing techniques, such as high-pressure and enzymatic hydrolysis, have revolutionized how bovine-based collagen is modified and refined to achieve superior bioactivity and application versatility. These shifts are characterized by a movement from conventional extraction practices to more sophisticated methods that optimize purity and performance. In parallel, emerging clinical needs in regenerative medicine and tissue engineering have directed research towards formulations that cater to specific cellular and molecular requirements. Increased regulatory scrutiny and demand for biocompatibility have also paved the way for advanced quality assurance protocols, ensuring that every product meets stringent industry standards. Additionally, heightened collaboration between research institutions, biotechnology sectors, and clinical practitioners has fostered an ecosystem where innovative solutions thrive. This environment not only supports incremental improvements but also paves the way for radical breakthroughs, ultimately transforming patient outcomes and driving the adoption of customized treatment modalities. As we delve deeper, it becomes evident that these transformative shifts are not isolated occurrences but part of an integrated evolution that is redefining biomedical applications globally.

In-Depth Segmentation Insights Shaping Market Dynamics

A nuanced evaluation of the market reveals distinct segmentation insights that underline the multifaceted nature of bovine-based collagen in biomedical applications. The product type segmentation categorizes the market into gelatin, hydrolyzed collagen, and native collagen where gelatin is further detailed through hydrolyzed and ultra filtered variants. Analysis by type distinguishes between Type I and Type III collagen, each exhibiting unique clinical properties. In terms of form, the differentiation between liquid and powder formulations addresses varying storage and application requirements. The source-based segmentation highlights materials obtained from bovine bone, cartilage, and skin, underscoring the diversity in raw material origins. Advancements in processing technology are equally pivotal, where methods such as enzymatic hydrolysis - which itself bifurcates into acidic and alkaline approaches - and high-pressure processing are emphasized. The application segment is layered further with delineations such as drug delivery systems, regenerative medicine with specific subcategories of cartilage repair and dermal fillers, tissue engineering, and wound care. Lastly, the end user analysis illustrates a market interplay among academic and research institutes, where basic biomedical research and clinical trials are conducted, biotechnology companies, and hospitals and clinics. These segmented insights collectively provide a detailed roadmap for stakeholders and innovators keen to tailor solutions for specific medical challenges.

Based on Product Type, market is studied across Gelatin, Hydrolyzed Collagen, and Native Collagen. The Gelatin is further studied across Hydrolyzed Gelatin and Ultra Filtered Gelatin.

Based on Type, market is studied across Type I and Type III.

Based on Form, market is studied across Liquid and Powder.

Based on Source, market is studied across Bovine Bone, Bovine Cartilage, and Bovine Skin.

Based on Processing Technology, market is studied across Enzymatic Hydrolysis and High-Pressure Processing. The Enzymatic Hydrolysis is further studied across Acidic Hydrolysis and Alkaline Hydrolysis.

Based on Application, market is studied across Drug Delivery Systems, Regenerative Medicine, Tissue Engineering, and Wound Care. The Regenerative Medicine is further studied across Cartilage Repair and Dermal Fillers.

Based on End User, market is studied across Academic And Research Institutes, Biotechnology Companies, and Hospitals And Clinics. The Academic And Research Institutes is further studied across Basic Biomedical Research and Clinical Trials.

Critical Regional Insights Influencing Global Market Trends

Geographical analysis provides a robust understanding of market dynamics and regional potential. In the Americas, the integration of advanced healthcare infrastructure and robust research investments has led to substantial progress in biomedical innovations utilizing bovine-based collagen. The region is characterized by high regulatory standards and strong capital flows into research and development initiatives. Meanwhile, the Europe, Middle East & Africa region exhibits a blend of established historical expertise in biomedical research and emerging market opportunities driven by innovative startups and collaborative research efforts. Regulatory frameworks and funding support in these territories continue to encourage pioneering developments in collagen processing and application. Asia-Pacific, on the other hand, stands out with its rapidly evolving manufacturing capacities and growing demand for technologically advanced medical devices. This region benefits from an increasing focus on cost-effective yet high-quality production techniques and is quickly becoming a hub for both clinical research and end-user adoption. Collectively, these regional insights underscore the importance of localized strategies in addressing diverse market requirements while providing a window into the global trajectory of bovine-based collagen in biomedical applications.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Prominent Company Profiles Driving Market Innovation

Market evolution in the biomedical domain is increasingly influenced by the strategic initiatives of leading companies that continually innovate and optimize bovine-based collagen products. Visionary organizations, including Advanced BioMatrix Inc. by BICP Group and Botiss biomaterials GmbH, are setting benchmarks in product quality and application specificity. Bovine Collagen Products LLC and Collagen Solutions PLC by Rosen's Diversified Inc. have established themselves as trailblazers in research and application development, forging critical partnerships with clinical entities. Companies like Crescent Biotech and Darling Ingredients Inc. leverage advanced processing techniques to enhance material performance, while Eucare Pharmaceuticals Private Limited and Getinge AB focus on delivering high-grade scaffolding solutions that support tissue regeneration. Integra LifeSciences Holdings Corporation and Lapi Gelatine S.p.A. have demonstrated a commitment to innovation through the integration of digital technologies and robust quality management systems. With firms such as Medtronic PLC, Nippi Incorporated, and Nitta Gelatin, Inc. leading clinical validations, and NuCollagen LLC, Regenity Biosciences along with Symatese Group, Tessenderlo Group balancing supply with high-demand applications, market consolidation is well underway. Titan Biotech Ltd., Thermo Fisher Scientific Inc., and Viscofan DE GmbH further highlight the dynamic interplay among key players, driving the competitive yet collaborative landscape of bovine-based collagen in modern biomedicine.

The report delves into recent significant developments in the Bovine-Based Collagen for Biomedical Applications Market, highlighting leading vendors and their innovative profiles. These include Advanced BioMatrix Inc. by BICP Group, Botiss biomaterials GmbH, Bovine Collagen Products LLC, Collagen Solutions PLC by Rosen's Diversified Inc., Crescent Biotech, Darling Ingredients Inc., Eucare Pharmaceuticals Private Limited, Getinge AB, Integra LifeSciences Holdings Corporation, Lapi Gelatine S.p.A., Medtronic PLC, Nippi Incorporated, Nitta Gelatin, Inc., NuCollagen LLC, Regenity Biosciences, Symatese Group, Tessenderlo Group, Thermo Fisher Scientific Inc., Titan Biotech Ltd., and Viscofan DE GmbH.

Strategic Recommendations for Industry Leaders and Innovators

For executives and innovators operating in the bovine-based collagen space, strategic agility and collaborative foresight are paramount. One critical recommendation is to continuously invest in research and development that targets advancements in processing technology; leveraging both high-pressure methods and refined enzymatic hydrolysis techniques can lead to enhanced product purity and heightened clinical efficacy. Emphasizing region-specific strategies can help address varied market demands and regulatory environments, ensuring that innovation is in step with local industry standards while pushing global benchmarks. Leaders are encouraged to adopt integrated analytical approaches that combine segmentation insights with regional and company performance data. Such analytical rigor facilitates the identification of high-value opportunities within drug delivery systems, regenerative medicine, tissue engineering, and wound care applications. Moreover, fostering partnerships between academic institutions, biotechnology companies, and clinical trial centers can result in a synergistic enhancement of product application and innovative exploration. It is equally important to maintain an agile supply chain that can adapt to technological changes and evolving market dynamics while ensuring compliance and optimized resource allocation. Strategic diversification in end-user focus - spanning clinical, research, and industrial segments - will maintain a competitive edge and drive sustainable growth within the biomedical sphere.

Synthesis and Forward-Looking Conclusions

In synthesizing the comprehensive data and strategic insights presented, it is evident that bovine-based collagen continues to solidify its role as a cornerstone in biomedical applications. The multifaceted analysis across product types, processing technologies, regional trends, and key industry players reveals a landscape that is both complex and rich with innovation opportunities. The dynamic shifts witnessed in extraction methods and applications underscore a period characterized by rapid technological progress and evolving clinical practices. Furthermore, the deep segmentation analysis provides an invaluable roadmap for addressing specific market needs and catalyzing targeted product offerings. As the market matures, the emphasis on regenerative medicine, tissue engineering, and customized drug delivery systems will further stimulate growth, while robust regulatory frameworks ensure that safety and efficacy remain uncompromised. This report not only reinforces the significant impact of bovine-based collagen on modern biomedical treatments but also charts a course for future industry developments. The forward-looking perspective is both a call to strategic action and a celebration of innovation, underscoring the necessity for continual advancement in this vital field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased awareness of collagen's therapeutic benefits fuels its use in diverse healthcare sectors
5.1.1.2. Rising investments in biomedical startups to expand their offerings
5.1.1.3. Growing aging of populations worldwide and increasing prevalence of bone-related diseases
5.1.2. Restraints
5.1.2.1. High costs associated with complex and intricate production processes
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for the development of wound healing and regenerative medicines
5.1.3.2. Growing demand for dental and orthopedic surgeries
5.1.4. Challenges
5.1.4.1. Ensuring safety and minimizing risk of disease transmission in bovine-derived collagen materials
5.2. Market Segmentation Analysis
5.2.1. Product Type : Wide applications of gelatin due to its versatility and biocompatibility
5.2.2. Application : Innovation in bovine-based collagen applications in regenerative medicine, drug delivery, and tissue engineering
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bovine-Based Collagen for Biomedical Applications Market, by Product Type
6.1. Introduction
6.2. Gelatin
6.2.1. Hydrolyzed Gelatin
6.2.2. Ultra Filtered Gelatin
6.3. Hydrolyzed Collagen
6.4. Native Collagen
7. Bovine-Based Collagen for Biomedical Applications Market, by Type
7.1. Introduction
7.2. Type I
7.3. Type III
8. Bovine-Based Collagen for Biomedical Applications Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Powder
9. Bovine-Based Collagen for Biomedical Applications Market, by Source
9.1. Introduction
9.2. Bovine Bone
9.3. Bovine Cartilage
9.4. Bovine Skin
10. Bovine-Based Collagen for Biomedical Applications Market, by Processing Technology
10.1. Introduction
10.2. Enzymatic Hydrolysis
10.2.1. Acidic Hydrolysis
10.2.2. Alkaline Hydrolysis
10.3. High-Pressure Processing
11. Bovine-Based Collagen for Biomedical Applications Market, by Application
11.1. Introduction
11.2. Drug Delivery Systems
11.3. Regenerative Medicine
11.3.1. Cartilage Repair
11.3.2. Dermal Fillers
11.4. Tissue Engineering
11.5. Wound Care
12. Bovine-Based Collagen for Biomedical Applications Market, by End User
12.1. Introduction
12.2. Academic And Research Institutes
12.2.1. Basic Biomedical Research
12.2.2. Clinical Trials
12.3. Biotechnology Companies
12.4. Hospitals And Clinics
13. Americas Bovine-Based Collagen for Biomedical Applications Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Bovine-Based Collagen for Biomedical Applications Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Bovine-Based Collagen for Biomedical Applications Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Scenario Analysis
16.3.1. RTI Surgical acquires Collagen Solutions to advance innovative biomedical applications
16.3.2. Royal Wound-X launches the Peak Powder Collagen Matrix and ElectroFiber 3D to enhance wound healing
16.3.3. MiMedx Group, Inc. entered an agreement with TELA Bio, Inc. to expand wound care portfolio with bovine collagen matrix innovation
16.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET MULTI-CURRENCY
FIGURE 2. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET MULTI-LANGUAGE
FIGURE 3. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET RESEARCH PROCESS
FIGURE 4. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 13. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 15. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 17. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 19. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 21. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 25. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 30. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 31. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET DYNAMICS
TABLE 7. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HYDROLYZED GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ULTRA FILTERED GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HYDROLYZED COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY NATIVE COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACIDIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ALKALINE HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HIGH-PRESSURE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BASIC BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 79. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 81. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 136. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 138. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 141. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 143. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 145. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 149. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 152. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 154. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 156. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 171. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 173. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 174. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 176. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 213. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 224. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 235. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 237. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 239. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 240. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 248. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILL

Companies Mentioned

  • Advanced BioMatrix Inc. by BICP Group
  • Botiss biomaterials GmbH
  • Bovine Collagen Products LLC
  • Collagen Solutions PLC by Rosen's Diversified Inc.
  • Crescent Biotech
  • Darling Ingredients Inc.
  • Eucare Pharmaceuticals Private Limited
  • Getinge AB
  • Integra LifeSciences Holdings Corporation
  • Lapi Gelatine S.p.A.
  • Medtronic PLC
  • Nippi Incorporated
  • Nitta Gelatin, Inc.
  • NuCollagen LLC
  • Regenity Biosciences
  • Symatese Group
  • Tessenderlo Group
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Ltd.
  • Viscofan DE GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.94 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Bovine-Based Collagen for Biomedical Applications - Global Strategic Business Report - Product Image

Bovine-Based Collagen for Biomedical Applications - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Bovine Based Collagen Market for Biomedical Applications 2024-2028 - Product Image

Bovine Based Collagen Market for Biomedical Applications 2024-2028

  • Report
  • 169 Pages
  • Global
From
Collagen and HA-Based Biomaterials - Global Strategic Business Report - Product Image

Collagen and HA-Based Biomaterials - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Collagen & HA-Based Biomaterials Market by Type, Application - Global Forecast 2025-2030 - Product Image

Collagen & HA-Based Biomaterials Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
2025 Medical and Research Grade Collagen Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Medical and Research Grade Collagen Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 148 Pages
  • Global
From

About the Market

Bovine collagen is a type of biomaterial derived from the hides and bones of cows. It is used in a variety of medical and cosmetic applications, including wound healing, tissue engineering, and drug delivery. Bovine collagen is a natural, biocompatible material that is highly biodegradable and has a low immunogenicity. It is also relatively inexpensive and easy to process. Bovine collagen is used in a variety of medical and cosmetic applications, including wound healing, tissue engineering, and drug delivery. It is also used in the production of medical devices, such as artificial skin, cartilage, and bone grafts. In addition, bovine collagen is used in the production of cosmetics, such as skin creams and lotions. The bovine collagen market is growing rapidly due to the increasing demand for biomaterials in medical and cosmetic applications. The market is expected to continue to grow in the coming years as new applications are developed and the demand for biomaterials increases. Some companies in the bovine collagen market include Collagen Solutions, Collagen Matrix, Inc., and Collagenex Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.